z-logo
open-access-imgOpen Access
Thymoquinone is a novel potential inhibitor of SIRT1 in cancers with p53 mutation: Role in the reactivation of tumor suppressor p73
Author(s) -
Mahmoud Alhosin
Publication year - 2020
Publication title -
world academy of sciences journal
Language(s) - English
Resource type - Journals
eISSN - 2632-2919
pISSN - 2632-2900
DOI - 10.3892/wasj.2020.49
Subject(s) - downregulation and upregulation , jurkat cells , cancer research , apoptosis , thymoquinone , sirtuin 1 , biology , cancer cell , cell culture , chemistry , microbiology and biotechnology , cancer , immunology , t cell , biochemistry , gene , genetics , immune system , antioxidant

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom